Skip to main content

Closed

IPHA: Innate Pharma S.A. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

40thpctl

Volume

0.14×avg

Market Cap

164.33MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Innate Pharma S.A.

IPHANASDAQ Global Select·USD·Closed

Innate Pharma S.A.

IPHANASDAQ·USD·Closed

$1.75

+0.29%

$1.75

+$0.00 (0.29%)

52W Range

40thpctl

Volume

0.14×avg

Mkt Cap

164.33MUSD

P/E

-2.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings